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Introduction {#sec1}
============

Protein sequences generally consist of 20 common amino acids. The UGA mRNA codon signals protein translation termination, but it can also be translated into selenocysteine (Sec, U), the 21st amino acid, when a Sec insertion sequence (SECIS) element in the mRNA 3′ untranslated region (3′ UTR), Sec tRNA, Sec-specific elongation factor, and the SECIS-binding protein SBP2 are present ([@bib40], [@bib47]). At least 25 selenoproteins, including glutathione peroxidase, thioredoxin reductase, and selenoprotein S (SELENOS, formerly known as valosin-containing protein \[VCP\]-interacting membrane protein) have been identified ([@bib10], [@bib11], [@bib21], [@bib56]). Selenoproteins are largely involved in oxidation-reduction reactions ([@bib10]). *In vitro*, SELENOS possesses both reductase and peroxidase activities, but only when Sec is incorporated and not when Sec is mutated to Cys ([@bib27], [@bib28]). These findings indicate the importance of Sec for the oxidoreductase activity of SELENOS.

UGA redefinition is regulated by selenium availability ([@bib14]) and involves a risk of premature translation termination. Indeed, Sec-containing mature and Sec-lacking truncated selenoproteins have been detected in human embryonic kidney (HEK)293 cells ([@bib24]). Human SELENOS consists of 189 amino acids, and Sec is the 188th amino acid. Therefore, it is difficult to distinguish mature and truncated SELENOS, and thus, it remains unknown how efficiently mature SELENOS is translated. SELENOS is a single transmembrane protein located at the ER membrane that eliminates misfolded proteins from the ER via retro-translocation in collaboration with VCP ([@bib7], [@bib56]). SELENOS expression is upregulated upon treatment with the ER stress-inducer tunicamycin (TM), which prevents N-linked protein glycosylation, and the knockdown of SELENOS inhibits membrane translocation of VCP and enhances ER stress-induced apoptosis ([@bib19], [@bib23]). Importantly, Pro178 and Pro183, but not Sec188, are important for interactions with VCP and ER-associated protein degradation (ERAD) ([@bib23]).

The two major functions of SELENOS, oxidoreductase activity and ERAD-related functions, are dependent or independent on Sec, respectively, indicating the importance of regulating the expression levels of mature and truncated SELENOS. Cullin 2 (Cul2)-containing ubiquitin ligase has been shown to target truncated but not mature SELENOS ([@bib24]). Cullin really interesting new gene (RING) ligases (CRLs) function in the ubiquitin proteasome system, and a protein complex consisting of Cul2, elongins B and C, von Hippel--Lindau (VHL) box protein, and RING-box protein 1 (RBX1) belongs to the CRL superfamily ([@bib16], [@bib26], [@bib38]). Proteins containing the VHL box target their substrate for ubiquitination and proteasomal degradation. Among VHL box proteins, Kelch domain-containing (KLHDC) 2 and 3 have been shown to destabilize truncated SELENOS directly or indirectly ([@bib24]). Five to seven Kelch repeats form a β-propeller structure that is involved in protein-protein interactions ([@bib1]). Recent research has revealed a "C-end rule," which implies that the amino acid sequence at the C terminus of a protein acts as a degron, a specific, short peptide motif of a substrate protein recognized by ubiquitin ligase ([@bib20], [@bib29], [@bib45]). KLHDC2 recognizes the C-terminal -Gly-Gly as a degron ([@bib20], [@bib25]), whereas KLHDC3 recognizes the C-terminal -Arg-(any amino acid, Xaa)~n~-Arg-Gly, -Arg-(Xaa)~n~-Lys-Gly, and -Arg-(Xaa)~n~-Gln-Gly sequences ([@bib20], [@bib25]). As the C terminus of mature SELENOS is -Gly-Gly-Sec-Gly, it is not recognized by KLHDC2/3. However, truncated SELENOS ends with -Gly-Gly, and thus, it is targeted by KLHDC2 for ubiquitination and proteasomal degradation. KLHDC2 is the best-studied Cul2-type ubiquitin ligase that targets truncated but not mature SELENOS.

KLHDC1, 2, and 3 belong to the same protein family; their identity and similarity, respectively, are as follows: 40.8% and 54.9% between KLHDC1 and KLHDC2, 23.1% and 34.2% between KLHDC1 and KLHDC3, and 23.5% and 36.7% between KLHDC2 and KLHDC3 (based on pairwise alignments using EMBOSS Needle, <https://www.ebi.ac.uk/Tools/psa/emboss_needle/>). Nevertheless, ectopic KLHDC1 and KLHDC2 predominantly localize to the cytoplasm and the nucleus, respectively ([@bib6]), suggesting that they have different biological roles. It has not clear whether KLHDC1 also targets truncated SELENOS, as does KLHDC2, and whether KLHDC1 also interacts with Cul2. The aim of the current study was to identify the substrate protein of KLHDC1. We purified and identified KLHDC1-interacting proteins in HEK293T cells by mass spectrometry. To study the hitherto unknown biological function of KLHDC1, we established KLHDC1-knockdown U2OS cell lines and examined ER stress-dependent cell death and reactive oxygen species (ROS) levels.

Results {#sec2}
=======

KLHDC1 Interacts with SELENOS and Cul5 {#sec2.1}
--------------------------------------

To identify the potential KLHDC1-interacting proteins by mass spectrometry, 3×FLAG-tagged KLHDC1 (3×FLAG-KLHDC1) was purified from HEK293T cell lysates. Cul5, but not Cul2, and SELENOS were identified as KLHDC1-interacting candidates. The peptides of SELENOS identified by mass spectrometry are shown in [Figure 1](#fig1){ref-type="fig"}A. To confirm this, 3×FLAG-KLHDC1, 3×FLAG-KLHDC2, and 3×FLAG-KLHDC3 were expressed in HEK293T cells, cell lysates were subjected to immunoprecipitation (IP) with an anti-FLAG antibody, and the immunoprecipitates were analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting (IB) with an anti-SELENOS or anti-FLAG antibody. The interaction between 3×FLAG-KLHDC1 and endogenous SELENOS was confirmed ([Figure 1](#fig1){ref-type="fig"}B). We also detected weak interaction between KLHDC2 and SELENOS. Given that the anti-SELENOS antibody recognizes both mature and truncated SELENOS, it was not clear which form is detected by KLHDC1. Next, 3×FLAG-KLHDC1, 3×FLAG-KLHDC2, and 3×FLAG-KLHDC3 were expressed in HEK293T cells, cell lysates were subjected to IP with an anti-FLAG antibody, and the immunoprecipitates were subjected to SDS-PAGE and IB with an anti-Cul2, anti-Cul5, or anti-FLAG antibody. In line with previously reported findings, KLHDC2 and KLHDC3 interacted with Cul2 ([@bib20], [@bib24], [@bib25]) ([Figure 1](#fig1){ref-type="fig"}C). In contrast, KLHDC1 interacted only with Cul5, suggesting the existence of a Cul5 box, but not a Cul2 box, in this protein ([@bib17], [@bib30], [@bib38]). The amino acid sequences of KLHDC1, KLHDC2, and KLHDC3 were aligned with those of well-known Cul2 box-containing proteins including VHL tumor suppressor (VHL), leucine-rich repeat protein (LRR)-1, feminization 1 (FEM1)A, and preferentially expressed antigen of melanoma (PRAME), as well as Cul5 box-containing proteins including cytokine-inducible Src homology 2 domain-containing protein (CIS), suppressor of cytokine signaling (SOCS)1, SOCS2, and SOCS3 ([Figure 1](#fig1){ref-type="fig"}D). This revealed that KLHDC1 contains a consensus Cul5 box sequence ϕxxLPϕPxxϕxxYL, whereas KLHDC2 and KLHDC3 contain the consensus Cul2 box sequence ϕPxxϕxxxϕ, where ϕ represents hydrophobic amino acids and x represents any amino acid. Next, we deleted the Cul5 box (amino acids 340--406) from KLHDC1 (KLHDC1(ΔCul5 box)), which resulted in a loss of interaction with Cul5 ([Figure 1](#fig1){ref-type="fig"}E). These findings indicated that KLHDC1 is a Cul5-interacting protein that recognizes SELENOS.Figure 1KLHDC1 Interacts with SELENOS and Cul5(A) Amino acid sequence of human SELENOS. Identified peptides by mass spectrometry are shown in bold font. U, selenocysteine.(B) SELENOS interacts with KLHDC1 and KLHDC2. 3×FLAG-KLHDC1, KLHDC2, or KLHDC3 was expressed in HEK293T cells, and cell lysates were subjected to immunoprecipitation (IP) with an anti-FLAG antibody and immunoblotted with an anti-FLAG or anti-SELENOS antibody.(C) KLHDC1 is a Cul5-type ubiquitin ligase. 3×FLAG-KLHDC1, KLHDC2, or KLHDC3 was expressed in HEK293T cells, and cell lysates were subjected to IP with an anti-FLAG antibody and immunoblotted with an anti-Cul2, anti-Cul5, or anti-FLAG antibody.(D) Amino acid sequence alignment of Cul2 box- or Cul5 box-containing human proteins. The numbers indicate the amino acid position in each protein. Conserved Cul5 box and Cul2 box sequences are shown at the bottom or the top of the box, respectively, in bold font. ϕ, hydrophobic residue.(E) Cul5 box-dependent interaction between KLHDC1 and Cul5. 3×FLAG-KLHDC1 (wild-type, WT) or a Cul5 box-deletion mutant KLHDC1(ΔCul5 box) was expressed in HEK293T cells, and cell lysates were subjected to IP with an anti-FLAG antibody and immunoblotted with an anti-Cul5 or anti-FLAG antibody.

KLHDC1 Destabilizes Truncated SELENOS (SELENOS(ΔSec)) {#sec2.2}
-----------------------------------------------------

KLHDC2 targets truncated but not mature SELENOS ([@bib20], [@bib25]). Therefore, we examined whether KLHDC1, which strongly interacts with SELENOS rather than KLHDC2 ([Figure 1](#fig1){ref-type="fig"}B), also destabilizes truncated SELENOS. A SELENOS(U188C) mutant is generally utilized as full-length native SELENOS in experiments because the plasmid construct used to express full-length Sec-containing SELENOS with the SECIS element in the 3′ UTR possibly produces both full-length and truncated SELENOS ([@bib24]), making it difficult to determine whether only full-length (or even, only truncated) SELENOS is expressed and how efficiently it is expressed. In this study, we also utilized SELENOS(U188C) as the full-length protein and compared it with SELENOS(ΔSec) in terms of its interaction with KLHDC1 ([Figures 2](#fig2){ref-type="fig"}A and 2B). Here, 3×FLAG-KLHDC1 and 3×hemagglutinin (HA)-tagged SELENOS(ΔSec or U188C) were expressed in HEK293T cells, cell lysates were subjected to IP with an anti-FLAG or anti-HA antibody, and the immunoprecipitates were subjected to SDS-PAGE and western blotting with an anti-HA or anti-FLAG antibody. 3×FLAG-KLHDC1 interacted with 3×HA-SELENOS(ΔSec) but not SELENOS(U188C) ([Figure 2](#fig2){ref-type="fig"}B). As KLHDC1 overexpression led to downregulation of the expression of SELENOS(ΔSec) but not SELENOS(U188C), we examined the protein stability of SELENOS(ΔSec) and SELENOS(U188C) in the presence or absence of KLHDC1 overexpression. HEK293T cells were transfected with expression vectors for 3×FLAG KLHDC1 and 3×HA SELENOS(ΔSec or U188C) and treated with the protein translation inhibitor cycloheximide, after which protein levels were determined. As shown in [Figure 2](#fig2){ref-type="fig"}C, both SELENOS(ΔSec) and SELENOS(U188C) were stable for at least 3 h in the absence of ectopic KLHDC1 expression. In contrast, SELENOS(ΔSec) expression was lower than that of SELENOS(U188C) with ectopic KLHDC1 expression. Nevertheless, SELENOS(ΔSec) was still stable for up to 3 h. Since SELENOS was transiently expressed in cells, the initial expression levels were slightly different, which was caused by different transfection efficiencies. For example, the expression of SELENOS(U188C) was slightly lower in the absence of 3×FLAG KLHDC1 compared with levels in the presence of 3×FLAG KLHDC1. These findings suggested that KLHDC1 binds to SELENOS(ΔSec) but not SELENOS(U188C) and destabilizes SELENOS(ΔSec) after more than 3 h under the conditions used in this study.Figure 2KLHDC1 Destabilizes Truncated SELENOS (SELENOS(ΔSec))(A) Alignment of the C-terminal amino acid sequence of human SELENOS and mutants. Wild-type SELENOS contains selenocysteine (U) before the last glycine (G). SELENOS(ΔSec) is produced by failed U incorporation during protein translation and results in (A) -GG end. SELENOS(U188C) is generally utilized as wild-type SELENOS.(B) KLHDC1 recognizes SELENOS(ΔSec) but not SELENOS(U188C). 3×HA-SELENOS(ΔSec) or SELENOS(U188C) was expressed in HEK293T cells, and cell lysates were subjected to immunoprecipitation (IP) with an anti-HA or anti-FLAG antibody and immunoblotted with an anti-HA or anti-FLAG antibody.(C) SELENOS(ΔSec) is weakly expressed in the presence of KLHDC1. 3×HA-SELENOS(ΔSec) or SELENOS(U188C) was expressed in HEK293T cells with or without 3×FLAG-KLHDC1. The cells were exposed to cycloheximide (25 μg/mL) for 1 or 3 h, and cell lysates were subjected to immunoblotting (IB) with an anti-HA or anti-FLAG antibody. Ponceau S staining rather than a particular protein, such as tubulin or actin, was used as a loading control.

Ubiquitination and Proteasome-Dependent Destabilization of SELENOS(ΔSec) by KLHDC1 {#sec2.3}
----------------------------------------------------------------------------------

As KLHDC1 was found to interact with Cul5 ([Figure 1](#fig1){ref-type="fig"}) and KLHDC2 and KLHDC3 act as Cul2-type ubiquitin ligases ([@bib20], [@bib24], [@bib25]), KLHDC1 was considered a potential Cul5-type ubiquitin ligase. Therefore, we examined whether downregulation of SELENOS(ΔSec) expression upon KLHDC1 overexpression depends on proteasome activity. 3×FLAG-KLHDC1 and 3×HA-SELENOS(ΔSec or U188C) were expressed in HEK293T cells that were then treated with the proteasome inhibitor MG132 (2 μM for 15 h), and cell lysates were subjected to SDS-PAGE and IB with an anti-HA, anti-FLAG, or anti-polyubiquitin antibody (FK2) ([Figure 3](#fig3){ref-type="fig"}A). SELENOS(ΔSec or U188C) did not accumulate upon MG132 treatment in the absence of 3×FLAG-KLHDC1. In contrast, SELENOS(ΔSec) but not SELENOS(U188C) accumulated upon MG132 treatment in the presence of 3×FLAG-KLHDC1, indicating that the downregulation of SELENOS(ΔSec) by 3×FLAG-KLHDC1 was achieved through proteasomal degradation. 3×FLAG-KLHDC1 was also degraded by the proteasome, and IB with an anti-polyubiquitin antibody showed that proteasome inhibition was the same in all samples. Next, polyubiquitination of SELENOS was examined in the presence or absence of 3×FLAG-KLHDC1 by utilizing His~6~-ubiquitin (His~6~-Ub) ([Figure 3](#fig3){ref-type="fig"}B). 3×FLAG-KLHDC1 and 3×HA-SELENOS(ΔSec or U188C) were expressed in HEK293T cells that were then treated with MG132 and lysed with 8 M urea-containing lysis buffer to dissociate any protein-protein interactions. His~6~-Ub and covalently His~6~-Ub-modified proteins were pulled down using Ni-agarose and subjected to SDS-PAGE and IB with an anti-HA, anti-FLAG, or anti-His~6~ antibody ([Figure 3](#fig3){ref-type="fig"}B). Results showed that 3×HA-SELENOS(ΔSec) and 3×HA-SELENOS(U188C) were polyubiquitinated. Importantly, the polyubiquitination of 3×HA-SELENOS(ΔSec) but not 3×HA-SELENOS(U188C) was increased with the co-expression of 3×FLAG-KLHDC1, verifying that KLHDC1 targets SELENOS(ΔSec). In addition, 3×FLAG-KLHDC1 was also shown to be polyubiquitinated under these experimental conditions. These findings indicated that KLHDC1 destabilizes SELENOS(ΔSec) but not SELENOS(U188C) via polyubiquitination and proteasomal degradation.Figure 3Ubiquitination and Proteasome-Dependent Destabilization of SELENOS(ΔSec) by KLHDC1(A) 3×HA-SELENOS(ΔSec) or SELENOS(U188C) was expressed in HEK293T cells, which were cultured in the presence or absence of MG132 (2 μM for 15 h). Cell lysates were subjected to immunoblotting (IB) with an anti-HA, anti-FLAG, or anti-polyubiquitin antibody. Ponceau S staining was used as a loading control.(B) KLHDC1-dependent ubiquitination of SELENOS(ΔSec). 3×HA-SELENOS(ΔSec) or SELENOS(U188C) was expressed in HEK293T cells with or without 3×FLAG-KLHDC1 and His~6~-ubiquitin (Ub). The cells were cultured in the presence of MG132 (2 μM for 15 h). Cell lysates containing 8 M urea, which prevents protein-protein interactions, were subjected to Ni-NTA agarose pull down to purify proteins modified by His~6~-Ub, followed by IB analysis with an anti-HA, anti-FLAG, or anti-His~6~ antibody.

SELENOS(ΔSec) Co-localizes with KLHDC1 {#sec2.4}
--------------------------------------

Microtubules (MTs) interact with ER-residing proteins and play important roles in ER membrane organization and dynamics in mammalian cells ([@bib13], [@bib46]). In previous studies, the overexpression of SELENOS(ΔSec) was found to change ER morphology to filamentous structures by interacting with MTs and the rough ER protein cytoskeleton-linking membrane protein (CLIMP)-63 but not the smooth ER protein receptor expression-enhancing protein 1 ([@bib35], [@bib56]). The knockdown of SELENOS resulted in the migration of the ER membrane proteins Sec61 and CLIMP-63 to the cell periphery, suggesting the involvement of SELENOS in ER structural organization ([@bib35]). In line with these previous findings, the overexpression of SELENOS(ΔSec) resulted in filamentous ER-MT bundles ([Figure 4](#fig4){ref-type="fig"}). It remained unclear whether mature SELENOS has similar activity; however, given that the overexpression of SELENOS(U188C) also resulted in filamentous ER-MT bundles, mature SELENOS might function in ER structural organization. Therefore, the quality control of SELENOS mediated by KLHDC1 is probably not important for its function in ER organization. Nevertheless, the localization of KLHDC1 was examined ([Figure 4](#fig4){ref-type="fig"}). Although ectopic KLHDC1 localized mainly to the cytosol upon co-overexpression with SELENOS(ΔSec), a very small fraction of KLHDC1 re-localized to the filamentous structures and co-localized with SELENOS(ΔSec), supporting the idea that KLHDC1 interacts with SELENOS(ΔSec) ([Figure 2](#fig2){ref-type="fig"}). In contrast, co-overexpression of SELENOS(U188C) did not lead to the re-localization of KLHDC1 to filamentous structures ([Figure 4](#fig4){ref-type="fig"}). These findings suggested that both mature and truncated SELENOS are involved in ER organization in collaboration with MTs and some ER-residing proteins and that the quality control of SELENOS mediated by KLHDC1 (i.e., degradation of truncated SELENOS) is not important for ER organization.Figure 4SELENOS(ΔSec) Co-localizes with KLHDC1U2OS cells expressing 3×HA-SELENOS(ΔSec) or SELENOS(U188C) with or without 3×FLAG-KLHDC1 were immunostained with anti-HA and anti-FLAG antibodies. Nuclei were stained with DAPI. Scale bar, 10 μm. Representative co-localization is indicated by white arrows.

KLHDC1 Enhances ER Stress-Induced U2OS Cell Death {#sec2.5}
-------------------------------------------------

We further examined whether KLHDC1 expression is induced by ER stress and if KLHDC1 affects ER stress-induced apoptosis. We utilized U2OS osteosarcoma cells, which express wild-type p53. U2OS cells were cultured in the presence of TM (1 μg/mL) for 24 h, and the expression of KLHDC1, SELENOS (mature and truncated forms), and VCP was analyzed ([Figure 5](#fig5){ref-type="fig"}A). KLHDC1 and SELENOS, but not VCP, were induced by TM treatment. If KLHDC1 targets SELENOS(ΔSec) but not mature SELENOS for proteasomal degradation, the downregulation of KLHDC1 should result in SELENOS(ΔSec) accumulation and total SELENOS should increase. Thus, we established two independent KLHDC1-knockdown cell lines (\#9 and \#14) and compared SELENOS expression (mature and truncated forms) in the presence or absence of TM treatment (1 μg/mL for 24 h; [Figures 5](#fig5){ref-type="fig"}B and 5C). Total SELENOS was slightly increased upon KLHDC1 knockdown only in the presence of TM. This result prompted us to examine selenium-dependent stabilization of SELENOS. U2OS cells were cultured without serum, which contains selenium at approximately 15 nM ([@bib44]) but might vary depending on the calf, for 15 h. Then, medium was changed, and cells were incubated for 1 day with or without TM (1 μg/mL) and different concentrations of selenium (0--500 nM) in the absence of serum. SELENOS was expressed and upregulated by TM treatment without selenium supplement, but expression was weaker than that in the selenium-supplemented condition ([Figure 5](#fig5){ref-type="fig"}D). Furthermore, 25 nM selenium was sufficient to upregulate SELENOS expression with or without TM treatment, implying that selenium is incorporated into SELENOS to produce full-length SELENOS, which is not recognized by KLHDC1 for proteasomal degradation. Nevertheless, it was suggested that the slight increase in total SELENOS was the result of SELENOS(ΔSec) accumulation ([Figures 5](#fig5){ref-type="fig"}B and 5C), that SELENOS(ΔSec) represents a minor fraction of these forms, and/or that another ubiquitin ligase such as KLHDC2 is also involved in the proteasomal degradation of SELENOS(ΔSec) as suggested previously ([@bib24]). The role of KLHDC1 in ER stress-induced apoptosis was examined by fluorescence-activated cell sorting (FACS; [Figures 5](#fig5){ref-type="fig"}E and 5F). Control and KLHDC1-knockdown U2OS cells (\#9 and \#14) were treated with TM and stained with propidium iodide (PI) and Annexin V. PI is a fluorescent intercalating agent, which is not membrane permeable, and therefore, it is useful to differentiate dead and healthy cells based on membrane integrity. Phosphatidylserine is located on the inner surface of the cell membrane but is exposed on the outside during apoptosis ([@bib52]). Annexin V is not membrane permeable and binds phosphatidylserine, thus recognizing apoptotic cells. The Annexin V-positive and PI-negative early-apoptotic cell populations (Q4 fraction in [Figure 5](#fig5){ref-type="fig"}E) and Annexin V and PI double-positive late-apoptotic cell populations (Q2 fraction in [Figure 5](#fig5){ref-type="fig"}E) were partly decreased by KLHDC1 knockdown. Q1 and Q3 fractions indicate non-apoptotic dead cell populations and viable cell populations, respectively. In other words, the loss of cell viability induced by TM treatment (from 89% to 49% of control cell) was partly rescued by KLHDC1 knockdown (from 89% to 57% of KLHDC1\#9 knockdown cells and from 90% to 62% of KLHDC1\#14 knockdown cells). Given that Pro178 and Pro183, but not Sec188, are important for interactions with VCP and ERAD ([@bib23]), SELENOS(ΔSec) accumulation upon KLHDC1 knockdown would contribute to ERAD and overcome ER stress-dependent cell death. Together, these findings suggested that ER stress-induced KLHDC1 targets SELENOS(ΔSec), which binds VCP and supports the degradation of undesirable proteins in the ER. Therefore, the downregulation of KLHDC1 led to a partial increase of total SELENOS and cell viability under ER stress and SELENOS(ΔSec) was suggested to be a minor fraction compared with mature SELENOS in the current experimental conditions.Figure 5KLHDC1 Enhances ER Stress-Induced U2OS Cell Death(A) KLHDC1 is induced by tunicamycin (TM) treatment. U2OS cells were cultured in the presence or absence of TM (1 μg/mL) for 24 h, and cell lysates were subjected to immunoblotting (IB) with an anti-KLHDC1, anti-SELENOS, or anti-VCP antibody. Ponceau S staining was used as a loading control.(B) Control or KLHDC1-knockdown (\#9 or \#14) U2OS cells were treated with TM (1 μg/mL) for 24 h, and cell lysates were subjected to IB with an anti-KLHDC1 or anti-SELENOS antibody. Ponceau S staining was used as a loading control.(C) Quantification of SELENOS expression in (B). SELENOS signals were normalized to those of ponceau S staining. Expression in control samples with TM treatment was set as 1. Data represent the mean ± SD of three independent experiments.(D) U2OS cells were cultured without serum for 15 h. Then, medium was changed, and cells were incubated for 1 day with or without TM (1 μg/mL) and different concentrations of selenium in the absence of serum. Cell lysates were subjected to IB with an anti-SELENOS antibody. Ponceau S staining was used as a loading control.(E) KLHDC1 knockdown partly prevents cell death induced by TM treatment. Control or KLHDC1-knockdown (\#9 or \#14) U2OS cells were treated with TM (1 μg/mL) for 24 h, and the cells were stained with propidium iodide (PI) and Annexin V and subjected to FACS analysis. PI-negative and Annexin V-negative populations represent viable cells. Cell numbers in Q1--4 indicate the cell population in each fraction. Representative data from three independent experiments are shown.(F) Cell viability of control and KLHDC1-knockdown (\#9 or \#14) U2OS cells after TM treatment. The viability of control knockdown cells with TM treatment was set as 1. Data represent the mean ± SD of three independent experiments. Statistical significance of differences was not considered, as described in the methods section.

ROS Production Is Decreased by Downregulating SELENOS in U2OS Cells {#sec2.6}
-------------------------------------------------------------------

The oxidoreductase activity of SELENOS *in vivo* and the underlying molecular mechanisms and substrate have not been well studied. Therefore, we examined global cellular ROS levels by staining cells with the superoxide indicator dihydroethidium (DHE) ([@bib12], [@bib50], [@bib53], [@bib57]). DHE is a cell-permeable blue fluorescent dye that upon reaction with superoxide anion forms a red fluorescent product, 2-hydroxyethidium, which intercalates DNA ([@bib53]). DHE is also oxidized by peroxynitrite (ONOO^−^), hydroxyl radical (⋅OH), and cytochrome *c* into ethidium ([@bib53]). The fluorescence spectra of 2-hydroxyethidium and ethidium are similar, and these oxidization products are generally both taken into account. We established two independent SELENOS-knockdown U2OS cell lines (\#210 and \#247) as reported previously ([@bib35]) ([Figure S1](#mmc1){ref-type="supplementary-material"}A). SELENOS-knockdown and control cells, as well as KLHDC1-knockdown cells, were cultured with or without TM (1 μg/mL) for 24 h, incubated with DHE (2 μM) for 30 min, and subjected to FACS ([Figure S1](#mmc1){ref-type="supplementary-material"}B). Cells were conveniently divided into two groups, comprising DHE staining positive and negative. KLHDC1 knockdown did not affect the ROS level in the presence or absence of TM (approximately 50%--60% of cells were DHE staining negative) compared with that in control cells (approximately 50% of cells were DHE staining negative). In contrast, SELENOS knockdown decreased ROS levels (approximately 70%--80% of cells were DHE staining negative) regardless of TM treatment ([Figure S1](#mmc1){ref-type="supplementary-material"}B). These findings suggested that SELENOS enhanced ROS production or decreased ROS removal activity. SELENOS is an oxidoreductase, and it is not clear whether fluctuations in ROS levels are dependent on SELENOS activity directly or indirectly. To confirm the importance of Sec in SELENOS, SELENOS-knockdown cells were reconstituted with SELENOS(ΔSec) or SELENOS(U188C) ([Figure S2](#mmc1){ref-type="supplementary-material"}A). SELENOS(ΔSec) was weakly expressed in control vector-transduced cells, probably because of KLHDC1 and KLHDC2-dependent proteasomal degradation. The expression of SELENOS(U188C) was stronger than that of SELENOS(ΔSec) but was downregulated upon TM treatment. SELENOS-knockdown and control cells were cultured with or without TM (1 μg/mL) for 24 h, incubated with DHE (2 μM) for 30 min, and analyzed by FACS ([Figure S2](#mmc1){ref-type="supplementary-material"}B). Cells were conveniently divided into two groups, comprising DHE staining positive and negative. Given that SELENOS(ΔSec) was weakly expressed, it was not clear whether it was involved in ROS production. SELENOS(U188C) did not affect the ROS level in the absence of TM treatment compared with that with control treatment (approximately 90% of both cell lines were DHE staining negative), indicating that the Sec residue of SELENOS is crucial for ROS production. Consistent herewith, Sec was shown to be required for SELENOS oxidoreductase activity ([@bib27]). TM did not affect ROS production in all conditions examined. These findings suggested that SELENOS promotes ROS production either directly or indirectly, although *in vitro*, SELENOS has reductase and peroxidase activities ([@bib27], [@bib28]). Finally, we examined the potential role of SELENOS in cell growth ([Figure S2](#mmc1){ref-type="supplementary-material"}C). SELENOS-knockdown cell lines grew faster than control cells, and SELENOS(U188C) expression did not affect cell growth. As ROS can initiate and prevent cancer development ([@bib32]), there might be a relationship between the increased U2OS cell growth and the reduced ROS level. Together, these findings indicated the importance of mature SELENOS for ROS production and cell growth.

Discussion {#sec3}
==========

Here, we propose that KLHDC1, like KLHDC2, recognizes the -Gly-Gly degron at the C terminus of SELENOS(ΔSec) and induces protein destabilization. Interestingly, unlike KLHDC2, which is a Cul2-type ubiquitin ligase, KLHDC1 is a Cul5-type ubiquitin ligase. Both Cul2- and Cul5-containing ubiquitin ligases contain elongins B and C, which are adaptor proteins connecting Cul2 or Cul5 to Cul2 or Cul5 box-containing proteins ([@bib17], [@bib30], [@bib38]). Elongin BC complexes containing Cul2-type and Cul5-type ubiquitin ligases are considered two distinct protein assemblies ([@bib17], [@bib30]). The fact that both KLHDC1 and KLHDC2 target SELENOS(ΔSec) suggests that these ubiquitin ligases might act in different circumstances and/or locations. The affinity of KLHDC2 for a SELENOS 8-aa degron was previously determined *in vitro* to be 21 nM ([@bib41]), but it might be different *in vivo*. KLHDC1 and KLHDC2 predominantly localize to the cytoplasm and nucleus, respectively ([@bib6]), which might reflect the high affinity of KLHDC1 for SELENOS. It might also be possible that a domain other than the SELENOS 8-aa degron might affect the affinity of KLHDC2 because full-length SELENOS was utilized in [Figure 1](#fig1){ref-type="fig"}B. KLHDC2 recognizes the -Gly-Gly degron of SELENOK(ΔSec), SELENOS(ΔSec), and the N-terminal proteolytic product of the deubiquitinating enzyme USP1 with different affinities, with SELENOK(ΔSec) showing the highest affinity ([@bib41]), suggesting that KLHDC2 recognizes not only the -Gly-Gly degron but also other parts of the substrate protein. Therefore, although both KLHDC1 and KLHDC2 recognize the -Gly-Gly degron of SELENOS(ΔSec), the affinities might be different because of the different amino acid sequences of KLHDC1 and KLHDC2, which recognize sequences other than the degron.

MTs play important roles in ER membrane organization and dynamics via dynamic and static interactions with ER-residing proteins ([@bib13], [@bib46]). ER and Golgi apparatus-residing syntaxin 5 long form (Syn5L) contributes to ER structural organization by interacting with CLIMP-63 and MTs ([@bib15], [@bib33]). SELENOS interacts with MTs through CLIMP-63 and Syn5L regardless of the presence of Sec at position 188; however, deletion of the C-terminus of SELENOS in SELENOS(1--146) results in the loss of these interactions and consequently decreased ER-MT-bundling activity ([@bib35]). Thus, mature SELENOS and SELENOS(ΔSec) seem to have similar roles in ER structural maintenance. In fact, SELENOS depletion causes migration of the ER to the cell periphery ([@bib35]), suggesting that the quality control of SELENOS mediated by KLHDC1 and KLHDC2 in part prevents irregular ER-MT bundling by downregulating the total amount of SELENOS.

Given that SELENOS is localized to the ER membrane and interacts with VCP ([@bib56]), its role in ERAD has been studied ([@bib18], [@bib19], [@bib23]). These studies revealed that SELENOS aids in the removal of unfolded proteins from the ER membrane in collaboration with VCP and reduces ER stress in the mouse macrophage cell line RAW 264.7, mouse neuroblastoma cell line Neuro-2a, and mouse preadipocyte cell line 3T3 L1. In contrast, SELENOS does not protect intestinal epithelial cells from oxidative cell death, the unfolded protein response, and ER stress ([@bib43]). In accordance herewith, we observed that SELENOS knockdown did not enhance TM-induced cell death (data not shown), although the increase in SELENOS induced by KLHDC1 knockdown partly protected U2OS cells from TM-induced cell death. These findings suggest that SELENOS depletion might activate other pathways to eliminate unexpected proteins from the ER membrane or that the degree of SELENOS contribution to ERAD might be cell type dependent. Nevertheless, it is suggested that SELENOS can support the removal of unwanted proteins.

The quality control of SELENOS mediated by KLHDC1 and KLHDC2 is expected to be important for maintaining oxidoreductase activity. It is assumed that a high level of Sec-containing mature SELENOS contributes to cell health by attenuating ER stress and maintaining the oxidoreductase system. KLHDC1 knockdown led to a slight increase in SELENOS(ΔSec), which supposedly is inactive, and as expected, we did not detect a difference in the ROS level in these cells. SELENOS knockdown decreased the ROS levels in cells, suggesting that SELENOS directly or indirectly produces ROS. The reduced glutathione content is slightly increased in SELENOS^−/−^ mice compared with that in wild-type littermates ([@bib2]), indicating the role of SELENOS in the oxidoreductase system. In fact, the mRNA expression of thioredoxin inhibitor protein and thioredoxin-1 is reduced in fast-twitch extensor digitorum longus (EDL) muscles but increased in soleus muscles in SELENOS^−/−^ mice when compared with that in wild-type littermates ([@bib2]). SELENOS knockout has no significant effect on mRNA expression of the ER stress chaperone glucose-regulated protein (Grp)78/binding immunoglobulin protein in EDL or soleus muscles ([@bib2], [@bib48]). However, the mRNA expression of *Grp94*, which is also an indicator of ER stress and encodes an HSP90-like chaperone in the ER lumen ([@bib22], [@bib31]), and CCAAT-enhancer-binding protein homologous protein were found to be reduced in SELENOS^−/−^ EDL muscles, whereas their expression was not affected in soleus muscles ([@bib2]). These findings indicated that SELENOS has distinct effects on ER stress and the oxidoreductase system in different muscle types. Increased ER stress induces the expression of a number of genes, leading to activation of nuclear factor-κB, which then activates the transcription of genes such as those encoding proinflammatory cytokines ([@bib39]). In fact, SELENOS suppresses inflammation, as indicated by the fact that SELENOS knockdown increases the production of *interleukin*-6 and tumor necrosis factor alpha in RAW264.7 macrophage cells ([@bib8]). Given that Sec is necessary for both the reductase and peroxidase activities of SELENOS, at least *in vitro* ([@bib27], [@bib28]), SELENOS(ΔSec) might have a dominant negative effect on Sec-containing mature SELENOS during oxidoreductase reactions. Therefore, the quality control of SELENOS, that is, the degradation of SELENOS(ΔSec) by KLHDC1 and KLHDC2, is important to maintain the oxidoreductase system.

KLHDC1 was found to act as a Cul5-type ubiquitin ligase that recognizes the -Gly-Gly degron of SELENOS(ΔSec), flagging it for proteasomal degradation ([Figure 6](#fig6){ref-type="fig"}). Both mature SELENOS and SELENOS(ΔSec) can interact with the VCP/Ufd1/Npl4 complex ([@bib5], [@bib23]) and degrade misfolded ER membrane-residing proteins to reduce ER stress. Interestingly, SELENOS is induced by ER stress and thus effectively contributes to ERAD. KLHDC1 is also induced by ER stress and degrades SELENOS(ΔSec), indicating that ERAD is partly prevented by a decrease in total SELENOS. This seems to be disadvantageous for ER stress reduction, but SELENOS also functions as an oxidoreductase. From this point of view, Sec is necessary for this activity, and SELENOS(ΔSec) might act as a dominant-negative enzyme by sequestering its physiological binding partner from mature SELENOS, thus suppressing the oxidoreductase system. The failed incorporation of selenium during protein translation and the lack of selenium intake led to a decrease in mature SELENOS and an increase in SELENOS(ΔSec). Therefore, KLHDC1-dependent degradation of SELENOS(ΔSec) would be important for maintenance of the oxidoreductase system.Figure 6Putative Model of KLHDC1 and SELENOS-Dependent Regulation of Endoplasmic Reticulum (ER)-Associated Protein Degradation (ERAD) and Oxidation-Reduction ReactionsMisfolded proteins on ER membranes induce ER stress responses and SELENOS expression. Both selenocysteine (Sec)-lacking SELENOS(ΔSec) and mature SELENOS interact with the VCP/Ufd1/Npl4 complex and contribute to the proteasomal degradation of misfolded proteins. Sec is involved in oxidation-reduction reactions, although the exact molecular mechanism has not been elucidated, and is expected to regulate reactive oxygen species (ROS) levels in the cell. The Cul5-type ubiquitin ligase KLHDC1 is also induced by ER stress and targets only SELENOS(ΔSec), not mature SELENOS, for ubiquitination and proteasomal degradation.

Selenoproteins such as glutathione peroxidase, thioredoxin reductase, and SELENOS are largely involved in oxidation-reduction reactions ([@bib10]), and selenium deficiency induces ER stress mainly by preventing native protein folding ([@bib49], [@bib54], [@bib55]). Therefore, the quality control of SELENOS by ER stress-induced KLHDC1 is crucial. Given that KLHDC2 targets -Gly-Gly-ended proteins, KLHDC1 might also target -Gly-Gly-ended proteins other than SELENOS(ΔSec) and contribute to C-end role-dependent eukaryotic proteome shaping as recently suggested ([@bib20]).

Limitations of the Study {#sec3.1}
------------------------

Unfortunately, a SELENOS(ΔSec)-specific antibody that can distinguish SELENOS(ΔSec) from mature SELENOS is currently not available, and mass-spectrometric quantification of both forms has remained unsuccessful. Therefore, it was impossible to separately quantify mature SELENOS and SELENOS(ΔSec), as well as the half-life and ubiquitination of these proteins.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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Document S1. Transparent Methods and Figures S1 and S2
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